Analystreport

Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its price target lowered by analysts at HC Wainwright from $14.00 to $8.00.

Aquestive Therapeutics, Inc.  (AQST) 
Last aquestive therapeutics, inc. earnings: 3/11 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aquestive.com/investor-relations